Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease

• Satheesh Chonat,
• Sara Graciaa,
• H. Stella Shin,
• Joanna G. Newton,
• Maa-Ohui Quarmyne,
• Jeanne Boudreaux,
• Amy Tang,
• Patricia E. Zerra,
• Margo R. Rollins,
• Cassandra D. Josephson,
• Clark Brown,
• Clinton H. Joiner,
• Ross M. Fasano,
• Sean R. Stowell

Affiliations

Satheesh Chonat

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;

Sara Graciaa

Aflac Cancer and Blood Disorders Center, Children Healthcare of Atlanta, Atlanta, GA, USA;

H. Stella Shin

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;

Joanna G. Newton

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;

Maa-Ohui Quarmyne

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;

Jeanne Boudreaux

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;

Amy Tang

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;

Patricia E. Zerra

Dept. of Pathology, Laboratory Medicine, Emory University School of Medicine, Atlanta, USA

Margo R. Rollins

Dept. of Pathology, Laboratory Medicine, Emory University School of Medicine, Atlanta, USA

Cassandra D. Josephson

Dept. of Pathology, Laboratory Medicine, Emory University School of Medicine, Atlanta, USA

Clark Brown

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;

Clinton H. Joiner

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;

Ross M. Fasano

Dept. of Pathology, Laboratory Medicine, Emory University School of Medicine, Atlanta, USA

Sean R. Stowell

Dept. of Pathology, Laboratory Medicine, Emory University School of Medicine, Atlanta, USA